Stem cells, megakaryocytes, and platelets
- 1 September 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 21 (5) , 430-437
Abstract
Stem cells are an important tool for the study of ex-vivo models of megakaryopoiesis and the production of functional platelets. In this manuscript, we review the optimization of megakaryocyte and platelet differentiation and discuss the mechanistic studies and disease models that have incorporated stem cell technologies. Mechanisms of cytoskeletal regulation and signal transduction have revealed insights into hierarchical dynamics of hematopoiesis, highlighting the close relationship between hematopoietic stem cells and cells of the megakaryocyte lineage. Platelet disorders have been successfully modeled and genetically corrected, and differentiation strategies have been optimized to the extent that utilizing stem cell-derived platelets for cellular therapy is feasible. Studies that utilize stem cells for the efficient derivation of megakaryocytes and platelets have played a role in uncovering novel molecular mechanisms of megakaryopoiesis, modeling and correcting relevant diseases, and differentiating platelets that are functional and scalable for translation into the clinic. Efforts to derive megakaryocytes and platelets from pluripotent stem cells foster the opportunity of a revolutionary cellular therapy for the treatment of multiple platelet-associated diseases.Keywords
This publication has 48 references indexed in Scilit:
- Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signalingJournal of Clinical Investigation, 2013
- Generation of Megakaryocytic Progenitors from Human Embryonic Stem Cells in a Feeder- and Serum-Free MediumPLOS ONE, 2013
- Infusion of Megakaryocytic Progenitor Products Generated from Cord Blood Hematopoietic Stem/Progenitor Cells: Results of the Phase 1 StudyPLOS ONE, 2013
- RAD001-mediated STAT3 upregulation and megakaryocytic differentiationThrombosis and Haemostasis, 2013
- RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidizationNature Communications, 2012
- The aryl hydrocarbon receptor (AHR) transcription factor regulates megakaryocytic polyploidizationBritish Journal of Haematology, 2011
- Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living miceCell Research, 2011
- Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cellsJournal of Experimental Medicine, 2010
- AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem CellsJournal of Biological Chemistry, 2008
- Wnt, Activin, and BMP Signaling Regulate Distinct Stages in the Developmental Pathway from Embryonic Stem Cells to BloodCell Stem Cell, 2008